跳至主要内容
临床试验/NCT01453465
NCT01453465撤回不适用

Gene Expression (GE) and MicroRNA (MIRNA) Expression Profiles of Malignant Rhabdoid Tumors (MRT) of the Kidney (RTK) and Atypical Teratoid Rhabdoid Tumor (ATRT)

Children's Oncology Group1 个研究点 分布在 1 个国家开始时间: 2011年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Molecular differences between RTK and the ATRT

研究概览

简要总结

This research trial studies biomarkers in samples from patients with rhabdoid tumor of the kidney and atypical teratoid rhabdoid tumor. Studying biomarkers of tissue samples from patients with cancer in the laboratory may help doctors learn more about changes the occur in DNA and identify biomarkers related to cancer.

详细描述

PRIMARY OBJECTIVES:

I. To determine if there are molecular differences between rhabdoid tumor of the kidney (RTK) and the atypical teratoid rhabdoid tumor (ATRT).

OUTLINE:

Archived tumor tissue samples are analyzed for gene expression profile and microRNA profile.

研究设计

研究类型
Observational

入排标准

性别
All
接受健康志愿者

入选标准

  • Samples of RTK and ATRT provided by the Children?s Oncology Group (COG)

排除标准

  • 未提供

结局指标

主要结局

Molecular differences between RTK and the ATRT

时间窗: Up to 3 months

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验